Dr. Sitruk-Ware describes the new options for hormone replacement therapy.
We have estrogens and progestins with various kind of design and structure that have specific actions, and some of them are better tolerated than others. However, now we are working also on selective estrogen receptor modulators, selective progesterone receptor modulators, and these are categories of new hormonal structures that can be better tolerated or more specific for the treatments of post-menopausal women.
About Dr. Sitruk-Ware, M.D.:
Dr. Régine L. Sitruk-Ware is a reproductive endocrinologist and the executive director of research and development at the Population Council’s Center of Biomedical Research. She supervises the basic research in reproductive biology as well as the pre-clinical research and clinical development of new molecules designed for reproductive healthcare in men and women suitable for use in developing countries. Prior to joining the Council, she had a successful academic career in Paris, France and then an international career in research and development. She taught and conducted clinical research in reproductive endocrinology at the University of Paris for ten years. From 1983 to 1989 she was a member of the International Committee for Contraceptive Research (ICCR), established by the Population Council in 1970. RSW is now chairing the ICCR since January 2007. She is a member of several national and international medical societies. She has been a founding member of the International Menopause Society and a member of its Board for several terms and is presently the General Secretary of that society. She is also member of the Expert group on Hormonal Contraception of the European Society for Contraception. She is the Program Director and Principal Investigator of a NIH Center grant from the National Institute of Child Health and Human Development.
View Dr. Sitruk-Ware Videos:
Visit Dr. Sitruk-Ware at the Population Council